Global pharma leader Lupin Limited has announced a major strategic shift by carving out its consumer healthcare arm, LupinLife Consumer Healthcare Ltd. (LCH), into a wholly owned subsidiary, effective today. The move is aimed at creating a focused, agile entity to tap into India’s fast-evolving self-care and over-the-counter (OTC) health product space.
LupinLife, launched in 2017, has built a strong footprint in the OTC segment with a science-backed product portfolio that includes well-known brands like Softovac®, Beplex Forte®, Corcium®, and Aptivate®. With this restructuring, Lupin is doubling down on its ambitions to strengthen consumer health offerings and deepen its reach in one of the world’s most dynamic wellness markets.
The newly carved-out company will be led by Anil Kaushal, who steps in as Chief Executive Officer. Under his leadership, the focus will be on unlocking new growth opportunities, expanding market presence, and scaling investments to drive stronger consumer connect and innovation.
Nilesh Gupta, Managing Director, Lupin, stated, “This strategic move reinforces our mission of developing high-impact businesses that drive sustained value. LCH exemplifies our unwavering dedication to patient-centric care and service to consumers.”
